Collegium Pharmaceutical, Inc
COLL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267565
No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Collegium Pharmaceutical, Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 228
- +36 vs. Q4 2023
- Shares held
- 39.6M
- +438.0K (+1.1%) vs. Q4 2023
- Total value
- $1.54B
- +$331.4M (+27.5%) vs. Q4 2023
- New holders
- 52
- 78 more added
- Sold out
- 16
- 78 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COLL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 279 | $1.42B |
| Q1 2026 | 267 | $1.26B |
| Q4 2025 | 279 | $1.72B |
| Q3 2025 | 243 | $1.29B |
| Q2 2025 | 223 | $1.06B |
| Q1 2025 | 241 | $1.10B |
| Q4 2024 | 238 | $1.06B |
| Q3 2024 | 249 | $1.49B |
| Q2 2024 | 229 | $1.28B |
| Q1 2024 | 228 | $1.54B |
| Q4 2023 | 193 | $1.21B |
| Q3 2023 | 175 | $865.2M |
| Q2 2023 | 178 | $843.5M |
| Q1 2023 | 199 | $936.9M |
| Q4 2022 | 179 | $837.7M |
| Q3 2022 | 169 | $574.6M |
| Q2 2022 | 157 | $645.5M |
| Q1 2022 | 172 | $733.9M |
| Q4 2021 | 159 | $669.4M |
| Q3 2021 | 155 | $719.5M |
| Q2 2021 | 159 | $898.3M |
| Q1 2021 | 163 | $900.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Collegium Pharmaceutical, Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Arrowstreet Capital, Limited Partnership | 278,513 | $10.8M | 0.01% | +59,165+27.0% | Added |
| Royce & Associates LP | 288,709 | $11.2M | 0.10% | +145,626+101.8% | Added |
| Bank of New York Mellon Corp | 307,631 | $11.9M | 0.00% | −15,021−4.7% | Reduced |
| Federated Hermes, Inc. | 329,531 | $12.8M | 0.03% | +116,763+54.9% | Added |
| Charles Schwab Investment Management Inc | 340,433 | $13.2M | 0.00% | +34,967+11.4% | Added |
| Avidity Partners Management LP | 361,400 | $14.0M | 0.50% | +370.0% | Added |
| LSV Asset Management | 380,551 | $14.8M | 0.03% | +248,751+188.7% | Added |
| Northern Trust Corp | 384,039 | $14.9M | 0.00% | −16,828−4.2% | Reduced |
| Emerald Mutual Fund Advisers Trust | 511,201 | $19.8M | 1.03% | −40,593−7.4% | Reduced |
| Victory Capital Management Inc | 525,963 | $20.4M | 0.02% | −197,334−27.3% | Reduced |
| Rock Springs Capital Management LP | 562,000 | $21.8M | 0.55% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 563,405 | $21.9M | 0.01% | −64,107−10.2% | Reduced |
| Massachusetts Financial Services Co | 661,798 | $25.7M | 0.01% | −3,320−0.5% | Reduced |
| Emerald Advisers, LLC | 669,512 | $26.0M | 1.05% | +3,416+0.5% | Added |
| Geode Capital Management, LLC | 733,548 | $28.5M | 0.00% | +2,282+0.3% | Added |
| Morgan Stanley | 836,944 | $32.5M | 0.00% | −164,807−16.5% | Reduced |
| Camber Capital Management LP | 852,900 | $33.1M | 1.16% | −197,100−18.8% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 969,199 | $37.6M | 0.16% | +969,199 | New |
| Dimensional Fund Advisors LP | 1,019,148 | $39.6M | 0.01% | −20,070−1.9% | Reduced |
| State Street Corp | 1,319,055 | $51.2M | 0.00% | +5,180+0.4% | Added |
| Renaissance Technologies LLC | 1,418,198 | $55.1M | 0.09% | +33,600+2.4% | Added |
| Principal Financial Group Inc | 1,552,857 | $60.3M | 0.04% | −16,294−1.0% | Reduced |
| Invesco Ltd. | 1,631,656 | $63.3M | 0.01% | +190,039+13.2% | Added |
| Rubric Capital Management LP | 1,834,027 | $71.2M | 2.10% | −924,226−33.5% | Reduced |
| Vanguard Group Inc | 2,330,728 | $90.5M | 0.00% | +17,942+0.8% | Added |
| Pacer Advisors, Inc. | 2,586,828 | $100.4M | 0.23% | +412,110+19.0% | Added |
| Eventide Asset Management, LLC | 2,634,041 | $102.3M | 1.60% | +3,563+0.1% | Added |
| BlackRock Inc. | 5,865,899 | $227.7M | 0.01% | +78,906+1.4% | Added |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −344,532−100.0% | Sold out |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −141,099−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −136,049−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −59,400−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −18,234−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,001−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −14,818−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −12,434−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,222−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −10,994−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −1,370−100.0% | Sold out |
| West Tower Group, LLC | 0 | $0 | 0.00% | −892−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −643−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −341−100.0% | Sold out |
| Abich Financial Wealth Management LLC | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Rosenberg Matthew Hamilton | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Watershed Asset Management, L.L.C. | – | – | – | – | Not filed |